Quest Diagnostics (DGX) Gross Profit (2009 - 2026)

Quest Diagnostics has disclosed Gross Profit across 18 years of filings, most recently posting $1.0 billion for Q2 2026.

• In Q2 2026, Gross Profit rose 8.91% year-over-year to $1.0 billion; the TTM figure through Jun 2026 stood at $3.8 billion (up 10.16% YoY), while the FY2025 annual figure was $3.7 billion, up 12.98% from the prior year.
• Gross Profit came in at $1.0 billion for Q2 2026 at Quest Diagnostics, up from $942.0 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $1.0 billion in Q2 2026 to a low of $736.0 million in Q4 2023.
• Average Gross Profit over 5 years is $853.6 million, with a median of $850.0 million recorded in 2022.
• Year-over-year, Gross Profit decreased 26.12% in 2022 and climbed 17.29% in 2025.
• Over 5 years, Gross Profit stood at $758.0 million in 2022, then decreased by 2.9% to $736.0 million in 2023, then grew by 16.58% to $858.0 million in 2024, then gained by 6.06% to $910.0 million in 2025, then climbed by 12.86% to $1.0 billion in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $1.0 billion in Q2 2026, $942.0 million in Q1 2026, and $910.0 million in Q4 2025.